Menarini Group and Radius Health Announce Positive Phase 3 Topline Results from the EMERALD Trial Evaluating Elacestrant in Breast Cancer | Radius Health, Inc.
The Investor Relations website contains information about Radius Health, Inc.’s business for stockholders, potential investors, and financial analysts.